Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vanadium and diabetes.

K H Thompson1

  • 1Medicinal Inorganic Chemistry Group, The University of British Columbia, Vancouver, Canada. kthompso@chem.ubc.ca

Biofactors (Oxford, England)
|September 4, 1999
PubMed
Summary
This summary is machine-generated.

Vanadium, an ultratrace element, shows potential in regulating cell signaling and energy metabolism. Research explores its use as a therapeutic agent for diabetes, examining both benefits and risks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Application of an equilibrium-based model for diffusion barrier charcoal canisters in a small volume non-steady state radon chamber.

Health physics·2011
Same author

Evaluation of total effective dose due to certain environmentally placed naturally occurring radioactive materials using a procedural adaptation of RESRAD code.

Health physics·2009
Same author

Vanadium compounds as insulin mimics.

Chemical reviews·2001
Same author

Cerebral glucose transport implies individualized glial cell function.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism·2001
Same author

Insulin-enhancing vanadium(III) complexes.

Inorganic chemistry·2001
Same author

Vanadyl-biguanide complexes as potential synergistic insulin mimics.

Journal of inorganic biochemistry·1999
Same journal

Dauriporphine Inhibits the Proliferation, Migration, Angiogenesis, and Glycolysis in Lung Cancer Cells by Repressing PGK1 Expression via CEBPA.

BioFactors (Oxford, England)·2026
Same journal

An AI-Driven Multi-Omics Framework Identifies CASP8 as a Clinically Actionable Pyroptosis Biomarker in Bladder Cancer.

BioFactors (Oxford, England)·2026
Same journal

Targeting the Tumor Immune Ecosystem in Glioblastoma: Challenges and Innovations in Immunotherapy.

BioFactors (Oxford, England)·2026
Same journal

Platelet-Related Gene Signature Predicts Prognosis, Immune Landscape, and Drug Sensitivity in Acute Myeloid Leukemia.

BioFactors (Oxford, England)·2026
Same journal

Resveratrol-Derived Dimers With Antimicrobial and Immune-Enhancing Activities.

BioFactors (Oxford, England)·2026
Same journal

Lysine Lactylation: Dynamic Regulation in the Tumor Microenvironment and Clinical Translational Prospects.

BioFactors (Oxford, England)·2026
See all related articles

Area of Science:

  • Bioinorganic chemistry
  • Metabolic research
  • Pharmacology

Background:

  • Vanadium is an ultratrace element with no established physiological role in mammals.
  • Emerging evidence suggests vanadium's involvement in intracellular signaling and energy metabolism.
  • Diabetes mellitus presents significant metabolic challenges.

Purpose of the Study:

  • To review the bioinorganic chemistry of vanadium.
  • To summarize the effects of vanadium compounds on diabetes.
  • To evaluate vanadium as a potential therapeutic adjunct for diabetes.

Main Methods:

  • Literature review of bioinorganic chemistry and vanadium's biological effects.
  • Analysis of in vitro and in vivo studies on vanadium compounds.

Related Experiment Videos

  • Examination of clinical trial data and tissue uptake kinetics.

    • Main Results:

    • Vanadium compounds show potential in regulating intracellular signaling and energy metabolism.
    • Both inorganic and organically-chelated vanadium have demonstrated effects in diabetes models.
    • Clinical trials and kinetic studies provide insights into vanadium's therapeutic potential and toxicity.

    Conclusions:

    • Vanadium's role in biological systems, particularly in diabetes, warrants further investigation.
    • Optimizing vanadium administration can enhance therapeutic benefits while minimizing toxicity.
    • Further research is needed to fully elucidate vanadium's potential as an oral therapeutic adjunct in diabetes management.